Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation

By C. Pappone, S. Rosanio, G. Oreto, M. Tocchi, F. Gugliotta, G. Vicedomini, A. Salvati, C. Dicandia, P. Mazzone, V. Santinelli and 2 more. Circulation, 2000

645 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/99085a6710dcc67edd9e8f8066cca3d4feb131b9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. M. Ezekowitz
2. Stanley Nattel
3. Gerhard Hindricks

Citations in the corpus

• Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation (2002, background): “%) were treated with a class I (10) or class III (5) antiarrhythmic drug.”
• Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation (2003, methodology): “However, the left atrial ablation technique used in this study also may have other effects that may be helpful in preventing PAF: (1) the ablation lines may eliminate anchor points for rotors or mother waves that drive AF10,11; (2) the vein of Marshall, which has a left atrial insertion in close pro”
• 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, methodology): “In an animal model of PAF, injection of parasympathomimetics into the fat pad adjacent to the PV-atrial junctions resulted in spontaneous or easily induced sustained AF, suggesting that a hyperactive ANS can play an important role in patients with focal AF arising from the PV.110,111 Stimulation of ”
• 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, methodology): “The endpoint for this procedure was amplitude reduction within the ablated area [205, 209], elimination (or dissociation) of the PV potentials recorded from either one or two circular mapping catheters or a basket catheter within the ipsilateral PVs [88, 89, 210, 212, 213, 215], and/or exit block fr”
• Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study (2008, neutral): “RS 13 (58) RI 6 (26) LS 6 (26) LI 2 ( 9 ) Gap in previous ablation lines, n (%) 8 (33) New lesions, n (%) 10 (42)”